BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 25504506)

  • 1. Arsenic trioxide transarterial chemoembolization with and without additional intravenous administration of arsenic trioxide in unresectable hepatocellular carcinoma with lung metastasis: a single-blind, randomized trial.
    Liu B; Huang JW; Li Y; Hu BS; He X; Zhao W; Zheng YB; Lu LG
    J Cancer Res Clin Oncol; 2015 Jun; 141(6):1103-8. PubMed ID: 25504506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized clinical control study of locoregional therapy combined with arsenic trioxide for the treatment of hepatocellular carcinoma.
    Wang H; Liu Y; Wang X; Liu D; Sun Z; Wang C; Jin G; Zhang B; Yu S
    Cancer; 2015 Sep; 121(17):2917-25. PubMed ID: 26033499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arsenic trioxide intravenous infusion combined with transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with pulmonary metastasis: Long-term outcome analysis.
    Hu HT; Yao QJ; Meng YL; Li HL; Zhang H; Luo JP; Guo CY; Geng X
    J Gastroenterol Hepatol; 2017 Feb; 32(2):295-300. PubMed ID: 27517972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arsenic trioxide combined with transarterial chemoembolization for primary liver cancer: A meta-analysis.
    Lv XH; Wang CH; Xie Y
    J Gastroenterol Hepatol; 2017 Sep; 32(9):1540-1547. PubMed ID: 28299819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-Agent versus Combination Doxorubicin-Based Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma: A Single-Blind, Randomized, Phase II Trial.
    Liu B; Huang JW; Li Y; Hu BS; He X; Zhao W; Zheng YB; Lu LG
    Oncology; 2015; 89(1):23-30. PubMed ID: 25613214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arsenic trioxide combined with transarterial chemoembolization for unresectable primary hepatic carcinoma: A systematic review and meta-analysis.
    Song P; Hai Y; Ma W; Zhao L; Wang X; Xie Q; Li Y; Wu Z; Li Y; Li H
    Medicine (Baltimore); 2018 May; 97(18):e0613. PubMed ID: 29718867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sorafenib in combination with transarterial chemoembolization and bronchial arterial chemoinfusion in the treatment of hepatocellular carcinoma with pulmonary metastasis.
    Duan F; Wang MQ; Liu FY; Wang ZJ; Song P; Wang Y
    Asia Pac J Clin Oncol; 2012 Jun; 8(2):156-63. PubMed ID: 22524574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large primary hepatocellular carcinoma: transarterial chemoembolization monotherapy versus combined transarterial chemoembolization-percutaneous microwave coagulation therapy.
    Xu LF; Sun HL; Chen YT; Ni JY; Chen D; Luo JH; Zhou JX; Hu RM; Tan QY
    J Gastroenterol Hepatol; 2013 Mar; 28(3):456-63. PubMed ID: 23216261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The clinical therapeutic effects of arsenic trioxide combined with transcatheter arterial chemoembolization in treating primary liver cancer with pulmonary metastases].
    Meng YL; Hu HT; Li HL; Guo CY; Luo JP; Yao QJ; Cheng HT; Xiao JC
    Zhonghua Nei Ke Za Zhi; 2012 Dec; 51(12):971-4. PubMed ID: 23327960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of refractory pulmonary metastases from hepatocellular carcinoma by transcatheter arterial chemoembolization using arsenic trioxide in combination with sorafinib].
    Hu H; Chen C; Li H
    Zhonghua Zhong Liu Za Zhi; 2015 Dec; 37(12):942-3. PubMed ID: 26887626
    [No Abstract]   [Full Text] [Related]  

  • 11. Roles played by chemolipiodolization and embolization in chemoembolization for hepatocellular carcinoma: single-blind, randomized trial.
    Shi M; Lu LG; Fang WQ; Guo RP; Chen MS; Li Y; Luo J; Xu L; Zou RH; Lin XJ; Zhang YQ
    J Natl Cancer Inst; 2013 Jan; 105(1):59-68. PubMed ID: 23150720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arsenic trioxide in patients with hepatocellular carcinoma: a phase II trial.
    Lin CC; Hsu C; Hsu CH; Hsu WL; Cheng AL; Yang CH
    Invest New Drugs; 2007 Feb; 25(1):77-84. PubMed ID: 16937079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sorafenib in combination with transarterial chemoembolization improves the survival of patients with unresectable hepatocellular carcinoma: a propensity score matching study.
    Bai W; Wang YJ; Zhao Y; Qi XS; Yin ZX; He CY; Li RJ; Wu KC; Xia JL; Fan DM; Han GH
    J Dig Dis; 2013 Apr; 14(4):181-90. PubMed ID: 23324079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arsenic trioxide-eluting Callispheres beads is more effective and equally tolerant compared with arsenic trioxide/lipiodol emulsion in the transcatheter arterial chemoembolization treatment for unresectable hepatocellular carcinoma patients.
    Duan XH; Ju SG; Han XW; Ren JZ; Li FY; Chen PF; Wu YY; Li H
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1468-1480. PubMed ID: 32096197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination therapy with transarterial chemoembolization and interferon-alpha compared with transarterial chemoembolization alone for hepatitis B virus related unresectable hepatocellular carcinoma.
    Li M; Lu C; Cheng J; Zhang J; Cao C; Xu J; Xu J; Pan H; Zhong B; Tucker S; Wang D
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1437-44. PubMed ID: 19486255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single- versus Triple-Drug Chemoembolization for Hepatocellular Carcinoma: Comparing Outcomes by Toxicity, Imaging Response, and Survival.
    Mouli SK; Hickey R; Thornburg B; Sato KT; Desai K; Gabr A; Kallini JR; Niemeri H; Kircher S; Mulcahy MF; Benson Iii AB; Gupta R; Salem R; Lewandowski RJ
    J Vasc Interv Radiol; 2016 Sep; 27(9):1279-1287. PubMed ID: 27062355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxaliplatin and 5-fluorouracil hepatic infusion with lipiodolized chemoembolization in large hepatocellular carcinoma.
    Li JH; Xie XY; Zhang L; Le F; Ge NL; Li LX; Gan YH; Chen Y; Zhang JB; Xue TC; Chen RX; Xia JL; Zhang BH; Ye SL; Wang YH; Ren ZG
    World J Gastroenterol; 2015 Apr; 21(13):3970-7. PubMed ID: 25852283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and Safety of Transarterial Chemoembolization Combined With Anlotinib for Unresectable Hepatocellular Carcinoma: A Retrospective Study.
    Guo W; Chen S; Wu Z; Zhuang W; Yang J
    Technol Cancer Res Treat; 2020; 19():1533033820965587. PubMed ID: 33089769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic analysis of transarterial chemoembolization combined with a traditional Chinese herbal medicine formula for treatment of unresectable hepatocellular carcinoma.
    Yu Y; Lang QB; Chen Z; Li B; Yu CQ; Zhu DZ; Huang XQ; Zhai XF; Ling CQ
    Chin Med J (Engl); 2009 Sep; 122(17):1990-5. PubMed ID: 19781383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcatheter arterial chemoembolization using CalliSpheres beads loaded with arsenic trioxide for unresectable large or huge hepatocellular carcinoma: a prospective study.
    Duan X; Li H; Chen P; Sun T; Kuang D; Lu H; Qiao B; Fan Z; Ren Z; Han X
    Eur Radiol; 2024 Feb; 34(2):1258-1267. PubMed ID: 37581654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.